Live News EQUITY FLASH L impact Oct 19, 2026, 04:31 PM UTC Piper Sandler Maintains Overweight Rating on BridgeBio Pharma Piper Sandler maintained its Overweight rating on BridgeBio Pharma. BBIO SquawkNews Desk